180 related articles for article (PubMed ID: 22970250)
21. A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
Kim HK; Choi IJ; Kim CG; Kim HS; Oshima A; Michalowski A; Green JE
PLoS One; 2011 Feb; 6(2):e16694. PubMed ID: 21364753
[TBL] [Abstract][Full Text] [Related]
22. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
[TBL] [Abstract][Full Text] [Related]
23. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
24. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.
Bie Q; Sun C; Gong A; Li C; Su Z; Zheng D; Ji X; Wu Y; Guo Q; Wang S; Xu H
Sci Rep; 2016 May; 6():25447. PubMed ID: 27146881
[TBL] [Abstract][Full Text] [Related]
25. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
26. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer.
Ichikawa W; Terashima M; Ochiai A; Kitada K; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):263-273. PubMed ID: 26884344
[TBL] [Abstract][Full Text] [Related]
27. Stem Cells Antigen-1 Enriches for a Cancer Stem Cell-Like Subpopulation in Mouse Gastric Cancer.
Park JW; Park JM; Park DM; Kim DY; Kim HK
Stem Cells; 2016 May; 34(5):1177-87. PubMed ID: 26869189
[TBL] [Abstract][Full Text] [Related]
28. Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling.
Li H; Wang Y
Med Sci Monit; 2019 Jan; 25():656-665. PubMed ID: 30670679
[TBL] [Abstract][Full Text] [Related]
29. Adhesion molecules alpha, beta and gamma-catenin as prognostic factors of tumour progression in upper urinary tract urothelial tumours: the role of AKT-P/GSK-3beta/beta-catenin pathway.
Izquierdo L; Truan D; Petit A; Gutiérrez R; Mallofré C; Alcaraz A
BJU Int; 2009 Jul; 104(1):100-6. PubMed ID: 19154502
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
[TBL] [Abstract][Full Text] [Related]
31. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
[TBL] [Abstract][Full Text] [Related]
32. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients.
Xiang D; Cheng Z; Liu H; Wang X; Han T; Sun W; Li X; Yang W; Chen C; Xia M; Liu N; Yin S; Jin G; Lee T; Dong L; Hu H; Wang H; Ding J
Hepatology; 2017 May; 65(5):1566-1580. PubMed ID: 28059452
[TBL] [Abstract][Full Text] [Related]
33. TIPE2 functions as a metastasis suppressor via negatively regulating β-catenin through activating GSK3β in gastric cancer.
Wu J; Zhang H; Xu C; Xu H; Zhou X; Xie Y; Tao M
Int J Oncol; 2016 Jan; 48(1):199-206. PubMed ID: 26530498
[TBL] [Abstract][Full Text] [Related]
34. Annonaceous acetogenins mediated up-regulation of Notch2 exerts growth inhibition in human gastric cancer cells in vitro.
Li Y; Ye J; Chen Z; Wen J; Li F; Su P; Lin Y; Hu B; Wu D; Ning L; Xue Q; Gu H; Ning Y
Oncotarget; 2017 Mar; 8(13):21140-21152. PubMed ID: 28416750
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.
Fan D; Ren B; Yang X; Liu J; Zhang Z
J Exp Clin Cancer Res; 2016 Nov; 35(1):177. PubMed ID: 27846906
[TBL] [Abstract][Full Text] [Related]
36. Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy.
Fareed KR; Soomro IN; Hameed K; Arora A; Lobo DN; Parsons SL; Madhusudan S
World J Gastroenterol; 2012 Apr; 18(16):1915-20. PubMed ID: 22563171
[TBL] [Abstract][Full Text] [Related]
37. Notch2-induced COX-2 expression enhancing gastric cancer progression.
Tseng YC; Tsai YH; Tseng MJ; Hsu KW; Yang MC; Huang KH; Li AF; Chi CW; Hsieh RH; Ku HH; Yeh TS
Mol Carcinog; 2012 Dec; 51(12):939-51. PubMed ID: 21976141
[TBL] [Abstract][Full Text] [Related]
38. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
[TBL] [Abstract][Full Text] [Related]
39. Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer.
Zheng H; Li W; Wang Y; Liu Z; Cai Y; Xie T; Shi M; Wang Z; Jiang B
Eur J Cancer; 2013 Aug; 49(12):2734-46. PubMed ID: 23582741
[TBL] [Abstract][Full Text] [Related]
40. eIF4EBP3 was downregulated by methylation and acted as a tumor suppressor by targeting eIF4E/β-catenin in gastric cancer.
Zhai S; Lin S; Lin Z; Xu J; Ji T; Chen K; Wu K; Liu H; Ying H; Fei W; Wang J; Fu G; Wang Y; Hu X; Cai X
Gastric Cancer; 2020 May; 23(3):483-496. PubMed ID: 31853750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
